Search

everythinglearnresearchcommunity

for

Search:↓

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Oral feline interferon-omega improved symptoms in diabetic cats with gingivostomatitis.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Targeting Vδ1+T-cells may help treat alopecia areata.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

COVID-19 vaccination may trigger lupus in some people.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

As of 1994, treatments for liver cancer had not significantly improved patient survival.